Yuan Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuan Yang has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
Han Zhang
Department of Neurology and Psychiatry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8 shared publicationsKe Shi
Department of Neurology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
6 shared publicationsCun Li
Department of Neurology and Psychiatry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5 shared publicationsJie Feng
Department of Neurology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
5 shared publicationsYanhui Song
Department of Neurology and Psychiatry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5 shared publicationsYe Xia
Department of Neurology and Psychiatry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (11)
Cortical Network Alterations and Treatment‐Induced Reorganization in Panic Disorder: A Longitudinal High‐Density EEG Study
Background: Although neuroimaging has identified network abnormalities in panic disorder (PD), the rapid and transient nature of panic symptoms highlights the need for methods with high temporal resolution. This study used high‐density electroencephalography (EEG) to investigate cortical network alterations in PD and explore their potential as translational biomarkers. Methods: This longitudinal study enrolled 52 drug‐naïve PD patients and 43 healthy controls. High‐density (128‐channel) resting‐state EEG was collected from both groups at baseline, with repeat assessments performed in PD patients after 6 weeks of venlafaxine treatment. Source‐level functional connectivity and network topology were analyzed to characterize cortical network features. Support vector machine (SVM) was used to evaluate the discriminative potential of baseline network features. Results: At baseline, PD patients showed frequency‐specific network disruptions, with enhanced connectivity within and between the default mode network, frontoparietal network, and dorsal attention network in the α band, but reduced connectivity across multiple networks in the θ and δ bands. Graph theory analysis revealed decreased global efficiency and increased characteristic path length in the α and δ bands. The SVM classifier achieved 86.32% accuracy in distinguishing PD patients from controls. Following treatment, clinical improvement was accompanied by network reorganization, including increased global efficiency and small‐worldness in the α band, and enhanced fronto‐temporal connectivity in the δ band. Exploratory brain–behavior associations did not survive FDR correction. Conclusions: PD is characterized by frequency‐specific cortical network disruptions that show dynamic reorganization following treatment. These findings highlight the potential of EEG‐derived network features as candidate markers for PD identification and treatment monitoring.
- 13 November 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (11)
Open AccessCortical Network Alterations and Treatment‐Induced Reorganization in Panic Disorder: A Longitudinal High‐Density EEG Study
Background: Although neuroimaging has identified network abnormalities in panic disorder (PD), the rapid and transient nature of panic symptoms highlights the need for methods with high temporal resolution. This study used high‐density electroencephalography (EEG) to investigate cortical network alterations in PD and explore their potential as translational biomarkers. Methods: This longitudinal study enrolled 52 drug‐naïve PD patients and 43 healthy controls. High‐density (128‐channel) resting‐state EEG was collected from both groups at baseline, with repeat assessments performed in PD patients after 6 weeks of venlafaxine treatment. Source‐level functional connectivity and network topology were analyzed to characterize cortical network features. Support vector machine (SVM) was used to evaluate the discriminative potential of baseline network features. Results: At baseline, PD patients showed frequency‐specific network disruptions, with enhanced connectivity within and between the default mode network, frontoparietal network, and dorsal attention network in the α band, but reduced connectivity across multiple networks in the θ and δ bands. Graph theory analysis revealed decreased global efficiency and increased characteristic path length in the α and δ bands. The SVM classifier achieved 86.32% accuracy in distinguishing PD patients from controls. Following treatment, clinical improvement was accompanied by network reorganization, including increased global efficiency and small‐worldness in the α band, and enhanced fronto‐temporal connectivity in the δ band. Exploratory brain–behavior associations did not survive FDR correction. Conclusions: PD is characterized by frequency‐specific cortical network disruptions that show dynamic reorganization following treatment. These findings highlight the potential of EEG‐derived network features as candidate markers for PD identification and treatment monitoring.
- Open Access
- 28 September 2026
- Published by Springer Nature in BMC Psychiatry
EEG microstate dynamics and source-space functional connectivity features for machine learning classification of major depressive disorder
- 28 September 2026
- Published by Springer Nature in BMC Psychiatry
Open AccessEEG microstate dynamics and source-space functional connectivity features for machine learning classification of major depressive disorder
- Open Access
- 5 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e91751
Self-Guided Internet-Based Mindfulness-Informed Stress Management for Generalized Anxiety Disorder: Randomized Controlled Trial With Longitudinal Network Analysis
Background: Generalized anxiety disorder (GAD) is characterized by stress-anxiety reinforcement cycles. Evidence for brief, self-guided, internet-based stress management as an adjunct to pharmacotherapy remains limited. Objective: This study aimed to evaluate the efficacy of an 8-week self-guided, internet-based stress management program (iSM) incorporating mindfulness techniques as an adjunct to treatment as usual (TAU) in adults with GAD and to examine individual predictors of response and symptom dynamics. Methods: A single-blind, parallel-group, superiority randomized controlled trial was conducted at Tongji Hospital, Wuhan, China. A total of 140 adults with GAD were randomly assigned to iSM+TAU (n=73) or TAU (n=67). Outcome assessors were blinded to group allocation. The iSM intervention consisted of 8 weekly self-guided online modules integrating mindfulness-based training and Baduanjin-based stretching exercises. TAU comprised routine pharmacotherapy. Primary outcomes were posttreatment changes in anxiety and depressive symptoms. Secondary outcomes included sleep quality, somatic symptoms, social functioning, mindfulness, rumination, and perceived stress. Exploratory cross-lagged panel network (CLPN) and random-intercept cross-lagged panel modeling (RI-CLPM) analyses were used to examine temporal symptom dynamics. Results: All 140 randomized participants were included in the intention-to-treat analysis. Compared with TAU, iSM+TAU showed greater reductions at posttreatment in anxiety (Cohen d =−0.277, 95% CI −0.521 to −0.033) and depressive symptoms (Cohen d =−0.309, 95% CI −0.592 to −0.026). Significant between-group differences were also observed in somatic symptoms (Cohen d =−0.340, 95% CI −0.604 to −0.077), state anxiety (Cohen d =−0.537, 95% CI −0.849 to −0.224), mindfulness (Cohen d =0.666, 95% CI 0.327-1.006), rumination (Cohen d =−0.344, 95% CI −0.626 to −0.062), and perceived stress (Cohen d =−0.429, 95% CI −0.725 to −0.133), but not in sleep quality or social functioning. No serious adverse events were reported. Median session completion was 7 of 8. In exploratory analyses, higher baseline acting with awareness predicted greater treatment response (standardized β=0.167; 95% CI 0.031-0.335), whereas higher trait anxiety predicted poorer outcomes (standardized β=−0.150; 95% CI −0.234 to −0.002). CLPN and RI-CLPM identified 2 key within-person pathways, a bidirectional association between perceived stress (mean β=0.219; P <.001) and state anxiety (mean β=0.165; P =.02), and a unidirectional effect of mindfulness on subsequent anxiety reduction (mean β=–0.285; P <.001). Conclusions: To our knowledge, this is the first trial to evaluate a brief, self-guided, culturally adapted digital mindfulness intervention as an adjunct to pharmacotherapy in Chinese adults with GAD. The intervention showed clinically meaningful benefits and practical potential as a scalable, resource-efficient approach. Unlike prior studies focused mainly on symptom outcomes alone, this trial combined a randomized design with CLPN and RI-CLPM analyses to provide preliminary insight into symptom change processes over time, adding a more process-oriented analytic perspective that may inform future intervention refinement.
- 5 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e91751
Open AccessSelf-Guided Internet-Based Mindfulness-Informed Stress Management for Generalized Anxiety Disorder: Randomized Controlled Trial With Longitudinal Network Analysis
Background: Generalized anxiety disorder (GAD) is characterized by stress-anxiety reinforcement cycles. Evidence for brief, self-guided, internet-based stress management as an adjunct to pharmacotherapy remains limited. Objective: This study aimed to evaluate the efficacy of an 8-week self-guided, internet-based stress management program (iSM) incorporating mindfulness techniques as an adjunct to treatment as usual (TAU) in adults with GAD and to examine individual predictors of response and symptom dynamics. Methods: A single-blind, parallel-group, superiority randomized controlled trial was conducted at Tongji Hospital, Wuhan, China. A total of 140 adults with GAD were randomly assigned to iSM+TAU (n=73) or TAU (n=67). Outcome assessors were blinded to group allocation. The iSM intervention consisted of 8 weekly self-guided online modules integrating mindfulness-based training and Baduanjin-based stretching exercises. TAU comprised routine pharmacotherapy. Primary outcomes were posttreatment changes in anxiety and depressive symptoms. Secondary outcomes included sleep quality, somatic symptoms, social functioning, mindfulness, rumination, and perceived stress. Exploratory cross-lagged panel network (CLPN) and random-intercept cross-lagged panel modeling (RI-CLPM) analyses were used to examine temporal symptom dynamics. Results: All 140 randomized participants were included in the intention-to-treat analysis. Compared with TAU, iSM+TAU showed greater reductions at posttreatment in anxiety (Cohen d =−0.277, 95% CI −0.521 to −0.033) and depressive symptoms (Cohen d =−0.309, 95% CI −0.592 to −0.026). Significant between-group differences were also observed in somatic symptoms (Cohen d =−0.340, 95% CI −0.604 to −0.077), state anxiety (Cohen d =−0.537, 95% CI −0.849 to −0.224), mindfulness (Cohen d =0.666, 95% CI 0.327-1.006), rumination (Cohen d =−0.344, 95% CI −0.626 to −0.062), and perceived stress (Cohen d =−0.429, 95% CI −0.725 to −0.133), but not in sleep quality or social functioning. No serious adverse events were reported. Median session completion was 7 of 8. In exploratory analyses, higher baseline acting with awareness predicted greater treatment response (standardized β=0.167; 95% CI 0.031-0.335), whereas higher trait anxiety predicted poorer outcomes (standardized β=−0.150; 95% CI −0.234 to −0.002). CLPN and RI-CLPM identified 2 key within-person pathways, a bidirectional association between perceived stress (mean β=0.219; P <.001) and state anxiety (mean β=0.165; P =.02), and a unidirectional effect of mindfulness on subsequent anxiety reduction (mean β=–0.285; P <.001). Conclusions: To our knowledge, this is the first trial to evaluate a brief, self-guided, culturally adapted digital mindfulness intervention as an adjunct to pharmacotherapy in Chinese adults with GAD. The intervention showed clinically meaningful benefits and practical potential as a scalable, resource-efficient approach. Unlike prior studies focused mainly on symptom outcomes alone, this trial combined a randomized design with CLPN and RI-CLPM analyses to provide preliminary insight into symptom change processes over time, adding a more process-oriented analytic perspective that may inform future intervention refinement.
- Open Access
- 6 October 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-9
Early treatment-related changes in dorsolateral prefrontal cortex activity and functional connectivity as potential biomarkers for antidepressant response in major depressive disorder
Cognitive deficits are prevalent in major depressive disorder (MDD). Given that the dorsolateral prefrontal cortex (DLPFC) is a crucial region within the executive control network, its activity and functional connectivity (FC) may serve as potential indicators of antidepressant response. This prospective cohort study recruited 115 MDD patients and 43 healthy controls. Psychological assessments, electroencephalogram and event-related potential recordings were performed at baseline and 1 week after venlafaxine treatment, with a 12-week follow-up. Independent sample t-tests and Mann-Whitney U tests analyzed group differences, while linear mixed-effects models and logistic regression evaluated associations between DLPFC activity/FC changes and clinical outcomes. The MDD group showed significantly reduced right DLPFC current density during the N2 time window evoked by oddball stimuli (p = 0.028). Higher right DLPFC current density during the N2 time window was correlated with lower HAMD-21 scores one week after treatment (p = 0.041, n = 46). Furthermore, an early increase predicted remission at week 12 (p = 0.005). Decreased beta-band FC between the left DLPFC and both side of posterior cingulate cortex (PCC) (left: p = 0.003; right: p = 0.004) were correlated with lower HAMD-21 scores (n = 71). Moreover, an early reduction in these connectivity measures (left: odds ratio (OR) = 0.534, 95% confidence interval (CI): 0.297–0.972, p = 0.036; right: OR = 0.533, 95% CI: 0.299–0.950, p = 0.033) predicted remission at week 12. Early changes in DLPFC activity and FC may serve as biomarkers for monitoring treatment efficacy and predicting clinical outcomes, informing personalized treatment approaches.
- 6 October 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-9
Open AccessEarly treatment-related changes in dorsolateral prefrontal cortex activity and functional connectivity as potential biomarkers for antidepressant response in major depressive disorder
Cognitive deficits are prevalent in major depressive disorder (MDD). Given that the dorsolateral prefrontal cortex (DLPFC) is a crucial region within the executive control network, its activity and functional connectivity (FC) may serve as potential indicators of antidepressant response. This prospective cohort study recruited 115 MDD patients and 43 healthy controls. Psychological assessments, electroencephalogram and event-related potential recordings were performed at baseline and 1 week after venlafaxine treatment, with a 12-week follow-up. Independent sample t-tests and Mann-Whitney U tests analyzed group differences, while linear mixed-effects models and logistic regression evaluated associations between DLPFC activity/FC changes and clinical outcomes. The MDD group showed significantly reduced right DLPFC current density during the N2 time window evoked by oddball stimuli (p = 0.028). Higher right DLPFC current density during the N2 time window was correlated with lower HAMD-21 scores one week after treatment (p = 0.041, n = 46). Furthermore, an early increase predicted remission at week 12 (p = 0.005). Decreased beta-band FC between the left DLPFC and both side of posterior cingulate cortex (PCC) (left: p = 0.003; right: p = 0.004) were correlated with lower HAMD-21 scores (n = 71). Moreover, an early reduction in these connectivity measures (left: odds ratio (OR) = 0.534, 95% confidence interval (CI): 0.297–0.972, p = 0.036; right: OR = 0.533, 95% CI: 0.299–0.950, p = 0.033) predicted remission at week 12. Early changes in DLPFC activity and FC may serve as biomarkers for monitoring treatment efficacy and predicting clinical outcomes, informing personalized treatment approaches.
- Open Access
- 3 October 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e76913
Gender Differences in Psychosocial Pathways to Depression and Anxiety: Cross-Sectional and Bayesian Causal Network Study
Background: Depression and anxiety are widespread disorders with documented gender differences in symptom progression and associated psychosocial factors. However, the complex interrelationships between childhood trauma, self-esteem, social support, emotion regulation, and their gender-specific impacts on the development of depression and anxiety remain unclear. Objective: The objective of this study was to investigate the network structures of depression, anxiety, and psychosocial factors and to examine the pathways contributing to the development of depression and anxiety, with a focus on gender-specific differences. Methods: This study included 6105 participants from across China, collecting their sociodemographic characteristics and psychological scale data. Cross-sectional network analysis was used to explore the complex relationships between depression, anxiety, insomnia, somatic symptoms, childhood trauma, self-esteem, social support, and emotional regulation. Subsequently, Bayesian network analysis was used to infer potential causal pathways. Gender differences in the network structures were specifically examined. Results: Network analysis revealed strong associations among depression, anxiety, insomnia, and somatic symptoms. Network strength centrality exhibited the highest stability across overall networks (CS-C=0.75), with high predictability for depression (R²=72.4%) and anxiety (R²=64%), supporting the robustness of the model. The network structure invariance test between male and female participants was significant (P=.001). Furthermore, the Bayesian network analysis showed gender-specific symptom progression, where anxiety preceded depression in male participants, while depression preceded anxiety in female participants (with edges retained in nearly 100% of bootstrap samples). Self-esteem, social support, and insomnia were central nodes in female participants, whereas emotion regulation was more influential in male participants. Additionally, childhood trauma influenced depression or anxiety indirectly through self-esteem and social support in both male and female participants. Conclusions: This study presents a novel application of network analyses to delineate distinct gender-specific pathways in the development of depression and anxiety. The findings underscore insomnia, self-esteem, and social support as intervention targets for women and emotion regulation for men. Findings support gender-sensitive mental health strategies and emphasize the need for longitudinal validation.
- 3 October 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e76913
Open AccessGender Differences in Psychosocial Pathways to Depression and Anxiety: Cross-Sectional and Bayesian Causal Network Study
Background: Depression and anxiety are widespread disorders with documented gender differences in symptom progression and associated psychosocial factors. However, the complex interrelationships between childhood trauma, self-esteem, social support, emotion regulation, and their gender-specific impacts on the development of depression and anxiety remain unclear. Objective: The objective of this study was to investigate the network structures of depression, anxiety, and psychosocial factors and to examine the pathways contributing to the development of depression and anxiety, with a focus on gender-specific differences. Methods: This study included 6105 participants from across China, collecting their sociodemographic characteristics and psychological scale data. Cross-sectional network analysis was used to explore the complex relationships between depression, anxiety, insomnia, somatic symptoms, childhood trauma, self-esteem, social support, and emotional regulation. Subsequently, Bayesian network analysis was used to infer potential causal pathways. Gender differences in the network structures were specifically examined. Results: Network analysis revealed strong associations among depression, anxiety, insomnia, and somatic symptoms. Network strength centrality exhibited the highest stability across overall networks (CS-C=0.75), with high predictability for depression (R²=72.4%) and anxiety (R²=64%), supporting the robustness of the model. The network structure invariance test between male and female participants was significant (P=.001). Furthermore, the Bayesian network analysis showed gender-specific symptom progression, where anxiety preceded depression in male participants, while depression preceded anxiety in female participants (with edges retained in nearly 100% of bootstrap samples). Self-esteem, social support, and insomnia were central nodes in female participants, whereas emotion regulation was more influential in male participants. Additionally, childhood trauma influenced depression or anxiety indirectly through self-esteem and social support in both male and female participants. Conclusions: This study presents a novel application of network analyses to delineate distinct gender-specific pathways in the development of depression and anxiety. The findings underscore insomnia, self-esteem, and social support as intervention targets for women and emotion regulation for men. Findings support gender-sensitive mental health strategies and emphasize the need for longitudinal validation.
- Open Access
- 28 August 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (5) , fcaf309
Sleep deprivation affects memory function, depression and anxiety-like behaviours in rats and mice: a systematic review and meta-analysis
Sleep deprivation paradigms have been employed in rat and mouse models to elucidate the function of sleep. The effects of sleep deprivation on memory function, as well as changes in depression- and anxiety-like behaviours, have been extensively investigated; however, the findings have often been inconsistent. In the present study, we conducted a comprehensive literature review of researches utilizing sleep deprivation paradigms in both rats and mice. A total of 164 original studies were analysed to extract results from behavioural tests concerning memory function and depression- and anxiety-like behaviours in wild-type rats or mice before and after sleep deprivation. The meta-analysis revealed that sleep deprivation consistently impaired memory function, irrespective of the paradigms, durations and species involved [P = 0.000, SMD (standardized mean difference) 95% CI (confidence intervals at 95%): −0.73 (−0.89, −0.57) for sleep deprivation; P = 0.000, SMD (95% CI): −0.75 (−0.93, −0.57) for rapid eye movement sleep deprivation]. Similar, albeit less pronounced, effects were observed on depression-like behaviours [P = 0.000, SMD (95% CI): −0.41 (−0.52, −0.29) for sleep deprivation; P = 0.000, SMD (95% CI): −0.60 (−0.79, −0.42) for rapid eye movement sleep deprivation]. The impact of sleep deprivation on anxiety-like behaviours was more variable. When considering both mice and rats, sleep deprivation generally exhibited anxiogenic effects [P = 0.049, SMD (95% CI): −0.19 (−0.39, −0.00) for sleep deprivation; P = 0.705, SMD (95% CI): 0.04 (−0.18, 0.27) for rapid eye movement sleep deprivation]. However, subgroup analyses indicated that rodent species and sleep durations demonstrated distinct responses to sleep deprivation. This study provides critical insights for selecting optimal paradigms, durations, species and behavioural tests in experimental designs.
- 28 August 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (5) , fcaf309
Open AccessSleep deprivation affects memory function, depression and anxiety-like behaviours in rats and mice: a systematic review and meta-analysis
Sleep deprivation paradigms have been employed in rat and mouse models to elucidate the function of sleep. The effects of sleep deprivation on memory function, as well as changes in depression- and anxiety-like behaviours, have been extensively investigated; however, the findings have often been inconsistent. In the present study, we conducted a comprehensive literature review of researches utilizing sleep deprivation paradigms in both rats and mice. A total of 164 original studies were analysed to extract results from behavioural tests concerning memory function and depression- and anxiety-like behaviours in wild-type rats or mice before and after sleep deprivation. The meta-analysis revealed that sleep deprivation consistently impaired memory function, irrespective of the paradigms, durations and species involved [P = 0.000, SMD (standardized mean difference) 95% CI (confidence intervals at 95%): −0.73 (−0.89, −0.57) for sleep deprivation; P = 0.000, SMD (95% CI): −0.75 (−0.93, −0.57) for rapid eye movement sleep deprivation]. Similar, albeit less pronounced, effects were observed on depression-like behaviours [P = 0.000, SMD (95% CI): −0.41 (−0.52, −0.29) for sleep deprivation; P = 0.000, SMD (95% CI): −0.60 (−0.79, −0.42) for rapid eye movement sleep deprivation]. The impact of sleep deprivation on anxiety-like behaviours was more variable. When considering both mice and rats, sleep deprivation generally exhibited anxiogenic effects [P = 0.049, SMD (95% CI): −0.19 (−0.39, −0.00) for sleep deprivation; P = 0.705, SMD (95% CI): 0.04 (−0.18, 0.27) for rapid eye movement sleep deprivation]. However, subgroup analyses indicated that rodent species and sleep durations demonstrated distinct responses to sleep deprivation. This study provides critical insights for selecting optimal paradigms, durations, species and behavioural tests in experimental designs.
- Open Access
- 9 May 2025
- Published by Springer Nature in Research Square
EEG Microstates and Functional Connectivity Abnormalities in Depressive Disorders: Diagnostic Potential and Machine Learning Application
Background: Diagnosis of depressive disorders (DD) primarily heavily relies on clinical interviews and subjective symptom reporting, highlighting the urgent need for objective biomarkers. This study aimed to identify novel electroencephalogram (EEG) features, utilizing high-density EEG and source localization techniques, to aid in the diagnosis of DD. Methods: Resting-state EEG data were collected from 115 patients with DD and 43 healthy controls (HCs). Microstate analysis and functional connectivity (FC) analysis were performed to extract EEG features. Statistical analyses were conducted to compare group differences, and a support vector machine (SVM) algorithm was applied to evaluate the diagnostic accuracy of these features. Results: Compared to HCs, DD patients showed a significant increased transition probability from microstate D to B (PFDR = 0.048). Additionally, significant elevations in FC within specific regions of the default mode network (DMN) were observed in the delta-band, theta-band, and beta-band (P < 0.05), as well as between parts of the DMN and the salience network (SN) in the theta-band and alpha-band (P < 0.05). However, none of these FC features survived after FDR correction (PFDR > 0.05). The classification accuracies for distinguishing DD patients from HCs using the SVM classifier were 66.7%, 76.2%, and 81.0% based on microstate features, FC features, and a combination of both, respectively. Conclusions: Patients with DD exhibited distinctive microstates and atypical alterations in brain network connectivity. Integrating these features with machine learning algorithms offers a promising approach to improving the objective diagnosis of DD. Trial registration: The study was registered on http://www.chictr.org.cn/ and the registration number was ChiCTR2200057365 (registration date: March 9, 2022).
- 9 May 2025
- Published by Springer Nature in Research Square
Open AccessEEG Microstates and Functional Connectivity Abnormalities in Depressive Disorders: Diagnostic Potential and Machine Learning Application
Background: Diagnosis of depressive disorders (DD) primarily heavily relies on clinical interviews and subjective symptom reporting, highlighting the urgent need for objective biomarkers. This study aimed to identify novel electroencephalogram (EEG) features, utilizing high-density EEG and source localization techniques, to aid in the diagnosis of DD. Methods: Resting-state EEG data were collected from 115 patients with DD and 43 healthy controls (HCs). Microstate analysis and functional connectivity (FC) analysis were performed to extract EEG features. Statistical analyses were conducted to compare group differences, and a support vector machine (SVM) algorithm was applied to evaluate the diagnostic accuracy of these features. Results: Compared to HCs, DD patients showed a significant increased transition probability from microstate D to B (PFDR = 0.048). Additionally, significant elevations in FC within specific regions of the default mode network (DMN) were observed in the delta-band, theta-band, and beta-band (P < 0.05), as well as between parts of the DMN and the salience network (SN) in the theta-band and alpha-band (P < 0.05). However, none of these FC features survived after FDR correction (PFDR > 0.05). The classification accuracies for distinguishing DD patients from HCs using the SVM classifier were 66.7%, 76.2%, and 81.0% based on microstate features, FC features, and a combination of both, respectively. Conclusions: Patients with DD exhibited distinctive microstates and atypical alterations in brain network connectivity. Integrating these features with machine learning algorithms offers a promising approach to improving the objective diagnosis of DD. Trial registration: The study was registered on http://www.chictr.org.cn/ and the registration number was ChiCTR2200057365 (registration date: March 9, 2022).
- 4 March 2025
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 184, 340-349
Circadian rhythm modulation in heart rate variability as potential biomarkers for major depressive disorder: A machine learning approach
- 4 March 2025
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 184, 340-349
Circadian rhythm modulation in heart rate variability as potential biomarkers for major depressive disorder: A machine learning approach
- Open Access
- 21 October 2024
- Published by Springer Nature in Research Square
Early Treatment-related Changes in Dorsolateral Prefrontal Cortex Activity and Functional Connectivity as Potential Biomarkers for Antidepressant Response in Major Depressive Disorder
Previous research has demonstrated that patients with major depressive disorder (MDD) exhibit cognitive deficits. As a crucial region within the executive control network, the dorsolateral prefrontal cortex (DLPFC) activity and its functional connectivity (FC) may serve as potential indicators of antidepressant response. This prospective cohort study recruited 115 MDD patients and 43 healthy controls. Psychological assessments, electroencephalogram and event-related potential recordings were performed at baseline and 1 week after venlafaxine treatment, with a 12-week follow-up. Group differences were analyzed using independent sample t-tests and Mann-Whitney U tests, while linear mixed-effects models and logistic regression evaluated associations between DLPFC activity/FC changes and clinical outcomes. The MDD group showed significantly reduced right DLPFC current density during the N2 time window evoked by oddball stimuli (p = 0.028), which negatively correlated with 21-item Hamilton Depression Rating Scale (HAMD-21) scores (p = 0.041) (n = 46). Furthermore, an early increase predicted remission at week 12 (p = 0.005). Decreased beta-band FC between the left DLPFC and both the left posterior cingulate cortex (PCC) (p = 0.003) and right PCC (p = 0.004) predicted lower HAMD-21 scores (n = 71). Moreover, an early reduction in these connectivity measures (left: odds ratio (OR) = 0.534, 95% confidence interval (CI): 0.297–0.972, p = 0.036; right: OR = 0.533, 95% CI: 0.299–0.950, p = 0.033) predicted remission at week 12. Early changes in DLPFC activity and FC may serve as biomarkers for monitoring treatment efficacy and predicting clinical outcomes, informing personalized treatment approaches.
- 21 October 2024
- Published by Springer Nature in Research Square
Open AccessEarly Treatment-related Changes in Dorsolateral Prefrontal Cortex Activity and Functional Connectivity as Potential Biomarkers for Antidepressant Response in Major Depressive Disorder
Previous research has demonstrated that patients with major depressive disorder (MDD) exhibit cognitive deficits. As a crucial region within the executive control network, the dorsolateral prefrontal cortex (DLPFC) activity and its functional connectivity (FC) may serve as potential indicators of antidepressant response. This prospective cohort study recruited 115 MDD patients and 43 healthy controls. Psychological assessments, electroencephalogram and event-related potential recordings were performed at baseline and 1 week after venlafaxine treatment, with a 12-week follow-up. Group differences were analyzed using independent sample t-tests and Mann-Whitney U tests, while linear mixed-effects models and logistic regression evaluated associations between DLPFC activity/FC changes and clinical outcomes. The MDD group showed significantly reduced right DLPFC current density during the N2 time window evoked by oddball stimuli (p = 0.028), which negatively correlated with 21-item Hamilton Depression Rating Scale (HAMD-21) scores (p = 0.041) (n = 46). Furthermore, an early increase predicted remission at week 12 (p = 0.005). Decreased beta-band FC between the left DLPFC and both the left posterior cingulate cortex (PCC) (p = 0.003) and right PCC (p = 0.004) predicted lower HAMD-21 scores (n = 71). Moreover, an early reduction in these connectivity measures (left: odds ratio (OR) = 0.534, 95% confidence interval (CI): 0.297–0.972, p = 0.036; right: OR = 0.533, 95% CI: 0.299–0.950, p = 0.033) predicted remission at week 12. Early changes in DLPFC activity and FC may serve as biomarkers for monitoring treatment efficacy and predicting clinical outcomes, informing personalized treatment approaches.